Table of Content




1. Executive Summary


2. Global Exosome Therapeutics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Exosome Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Exosome Therapeutics Market by Type
3.3.1: Natural Exosome
3.3.2: Hybrid Exosome

3.4: Global Exosome Therapeutics Market by Application
3.4.1: Metabolic Disorders
3.4.2: Oncology
3.4.3: Cardiac Disorders
3.4.4: Neurology
3.4.5: Inflammatory Disorders
3.4.6: Organ Transplantation
3.4.7: Gynecology Disorders
3.4.8: Blood Disorders
3.4.9: Others

3.5: Global Exosome Therapeutics Market by End Use
3.5.1: Research & Academic Institutes
3.5.2: Hospitals & Diagnostic Centers





4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Exosome Therapeutics Market by Region
4.2: North American Exosome Therapeutics Market
4.2.2: North American Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers


4.3: European Exosome Therapeutics Market
4.3.1: European Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.3.2: European Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers


4.4: APAC Exosome Therapeutics Market
4.4.1: APAC Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.4.2: APAC Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers


4.5: ROW Exosome Therapeutics Market
4.5.1: ROW Exosome Therapeutics Market by Type: Natural Exosome and Hybrid Exosome
4.5.2: ROW Exosome Therapeutics Market by End Use: Research & Academic Institutes and Hospitals & Diagnostic Centers



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Exosome Therapeutics Market by Type
6.1.2: Growth Opportunities for the Global Exosome Therapeutics Market by Application
6.1.3: Growth Opportunities for the Global Exosome Therapeutics Market by End Use

6.1.4: Growth Opportunities for the Global Exosome Therapeutics Market by Region

6.2: Emerging Trends in the Global Exosome Therapeutics Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Exosome Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Therapeutics Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Church & Dwight
7.2: GSK
7.3: Pfizer
7.4: Sun Pharmaceutical
7.5: Takeda Pharmaceutical
7.6: F. Hoffmann-La Roche
7.7: CELGENE Corporation